Armando Anido

Track

Insider profile

Currently holds positions in Zynerba Pharmaceuticals Inc and SCYNEXIS Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Zynerba Pharmaceuticals Inc Oct. 1, 2014 -
Director SCYNEXIS Inc Jan. 21, 2019 -
Independent Director Vaxart Inc Sept. 22, 2015 - Feb. 13, 2018
Armando Anido's trades of Zynerba Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US SCYNEXIS Inc (SCYX)
Transaction date
Purchase
Price
6.25
Quantity 5,000 +inf%
Value US$31,250
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-14 2023-09-13
S Sale
89,410 -15.8%
172.72
US$820,268 		89,410 -15.8% 172.72 US$820,268
2023-01-25 2023-01-23
S Sale
67,409 +1.0%
70.55
US$369,462 		67,409 +1.0% 70.55 US$369,462
2022-07-20 2022-07-19
S Sale
26,230 +16.3%
61.50
US$4,451,931 		26,230 +16.3% 61.50 US$4,451,931
2020-12-23 2020-12-21
US SCYNEXIS Inc (SCYX)
B Purchase
5,000 +inf%
6.25
US$31,250 		5,000 +inf% 6.25 US$31,250